Lv4
570 积分 2024-05-28 加入
Safety, Pharmacokinetics, and Efficacy of Asandeutertinib in Advanced EGFR-mutated NSCLC: A Phase 1 Dose-Escalation and Dose-Expansion Study
30天前
已完结
Biotech Investing: Every Investor's Guide
1个月前
已关闭
Understanding Pharma
1个月前
已关闭
Rapid tumor regression in an Asian lung cancer patient following personalized neo-epitope peptide vaccination
1个月前
已完结
Safety, Pharmacokinetics, and Efficacy of Asandeutertinib in Advanced EGFR-mutated NSCLC: A Phase 1 Dose-Escalation and Dose-Expansion Study
1个月前
已完结
The emerging landscape and future perspective of SCLC transformation: From molecular mechanisms to therapeutic strategies
1个月前
已完结
Subcutaneous daratumumab in Chinese patients with relapsed or refractory multiple myeloma: an open-label, multicenter, phase 1 study (MMY1010)
2个月前
已完结
Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial
2个月前
已完结
The multifunctional role of hydroxyapatite nanoparticles as an emerging tool in tumor therapy
2个月前
已完结
First Report of NSCLC With IDH1 Mutation: A Case Report
2个月前
已完结
皖公网安备34019202002308
